Exercise and drug combo may boost heart health in metabolic syndrome

NCT ID NCT04575844

Recruiting now Disease control Sponsor: University of Virginia Source: ClinicalTrials.gov ↗

First seen May 14, 2026 · Last updated May 14, 2026

Summary

This study looks at whether exercise, a drug called liraglutide, or both can improve blood flow to the heart and muscles and help the body use insulin better in adults with metabolic syndrome. About 80 people aged 21 to 60 will be placed into one of four groups: control, exercise only, liraglutide only, or both. They will be monitored for 24 weeks to see how these treatments affect blood vessel health and insulin action.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METABOLIC SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

University of Virginia
RECRUITING

Charlottesville, Virginia, 22906, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

METABOLIC SYNDROME